Terumo traded at 2,094.50 this Wednesday March 25th, increasing 6.00 or 0.29 percent since the previous trading session. Looking back, over the last four weeks, Terumo gained 2.30 percent. Over the last 12 months, its price fell by 25.44 percent. Looking ahead, we forecast Terumo to be priced at 1,951.12 by the end of this quarter and at 1,709.56 in one year, according to Trading Economics global macro models projections and analysts expectations.
TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.